Effects of topically applied sulphur mustard on tissue glycogen, blood glucose, lactate and pyruvate in mice. 1992

K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
Division of Pharmacology and Toxicology, Defence Research and Development Establishment, Gwalior.

Bis-2-Chloroethyl sulphide, commonly known as sulphur mustard (SM) or mustard gas, an alkylating agent, is frequently used as a chemical warfare agent. Inhibition of glycolysis has been related to skin injury and cell death. The effects of SM on tissue glycogen, blood glucose, lactate/pyruvate ratio were investigated in the present study. After a single dermal application of 1.0 LD50 SM in mice, a significant hyperglycemia was observed at 24 hr post exposure. There was a corresponding decrease in liver glycogen content, with no alteration in glycogen content of brain, muscles and kidney. Blood pyruvate and lactate levels were not appreciably altered.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009151 Mustard Gas Severe irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung edema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP-85-002, 1985) (Merck, 11th ed). Dichlorodiethyl Sulfide,Sulfur Mustard,Bis(beta-chloroethyl) Sulfide,Di-2-chloroethyl Sulfide,Mustardgas,Psoriazin,Yellow Cross Liquid,Yperite,Di 2 chloroethyl Sulfide,Gas, Mustard,Mustard, Sulfur,Sulfide, Di-2-chloroethyl,Sulfide, Dichlorodiethyl
D011773 Pyruvates Derivatives of PYRUVIC ACID, including its salts and esters.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D006003 Glycogen
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
January 1997, Journal of applied toxicology : JAT,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
January 1996, Journal of applied toxicology : JAT,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
January 1966, The British journal of nutrition,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
March 1965, Biochemical pharmacology,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
September 1978, Journal of applied physiology: respiratory, environmental and exercise physiology,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
January 1975, The Journal of the Egyptian Medical Association,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
March 1966, Biochemical pharmacology,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
January 1994, Neuroreport,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
December 1963, Nihon juigaku zasshi. The Japanese journal of veterinary science,
K Sugendran, and K Jeevaratnam, and K Husain, and R Singh, and D K Srivastava
November 1984, Clinical and experimental dermatology,
Copied contents to your clipboard!